Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05568927 · ClinicalTrials.gov registry record

Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism

A clinical trial, sponsored by University of California, San Diego.

Completed
Registry status
150
Enrollment target

NCT05568927: Completed study, sponsored by University of California, San Diego.

NCT05568927 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05568927 has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
150 participants
Enrollment target

Study Summary

Potential outcomes after PE occur on a spectrum: complete recovery, exercise intolerance from deconditioning/anxiety, dyspnea from concomitant cardiopulmonary conditions, dyspnea from residual pulmonary vascular occlusion, chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension. Although a battery of advanced diagnostic tests could distinguish each of those conditions, the yield of individual tests among all post- PE patients is low enough that routine testing of all PE patients is not typically performed. Although the various possible post-PE outcomes have enormous implications for patient care, they are rarely distinguished clinically. Perhaps for this reason, chronic conditions after PE are rarely (if ever) used as endpoints in randomized clinical trials of acute PE treatment. The proposed project will validate a clinical decision tree to distinguish among the various discrete outcomes cost-effectively through a hierarchical series of tests with the acronym SEARCH (for symptom screen, exercise function, arterial perfusion, resting heart function, confirmatory imaging and hemodynamics). Each step of the algorithm sorts a subset of patients into a diagnostic category unequivocally in a cost-effective manner. The categories are mutually exclusive and collectively exhaustive, so that each case falls into one, and only one, category. Each individual test used in the algorithm has been clinically validated in pulmonary embolism patients, including the cardiopulmonary exercise test (CPET) technique that the investigators developed and validated. However, the decision tree approach to deploying the tests has not yet been validated. Aim 1 will determine whether the SEARCH algorithm will yield concordant post-PE diagnoses when multiple reviewers independently evaluate multiple cases (reliability). Aim 2 will determine whether the post-PE diagnoses are stable, according to the SEARCH algorithm, between the first evaluation and the subsequent one

Primary Outcome

Based on a structured evaluation of clinical data generated during long term follow-up after PE and presented in a de-identified manner, six observers will independently categorize each patient as one of the following: 1. complete recovery from dyspnea and exercise intolerance to the state that pre-existed PE or dyspnea after PE but cardiopulmonary exercise test showing normal ventilatory dead space proportions (VD/VT) and normal estimated stroke volume augmentation (SVA) during exercise; 2. dy

Interventions

  • OTHER SEARCH algorithm

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-11-15
Est. Completion 2025-06-13
University of California, San Diego

775 total trials

What the finished NCT05568927 record still lists

NCT05568927 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which SEARCH algorithm is the first listed.

NCT05568927 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05568927 about?

NCT05568927 is a clinical study titled "Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism". Potential outcomes after PE occur on a spectrum: complete recovery, exercise intolerance from deconditioning/anxiety, dyspnea from concomitant cardiopulmonary conditions, dyspnea from residual pulmonary vascular occlusion, chronic thromboembolic disease and chronic thromboembolic pulmonary hypertens...

What is the current status of trial NCT05568927?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2022-11-15. Estimated completion is 2025-06-13.

What interventions are being tested in trial NCT05568927?

The interventions under investigation include: SEARCH algorithm (OTHER).

Who is sponsoring clinical trial NCT05568927?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05568927, the US trial registry maintained by the National Library of Medicine. NCT05568927 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.